Institutional Ownership Zentalis Pharmaceuticals, Inc. (ZNTL)
This table provides information about the institutional ownership of Zentalis Pharmaceuticals, Inc. (ZNTL). We have compiled data on the 141 institutions that hold shares in the stock, with a total of 67.9 Million shares, which have been reported (via 13F filing form) to have a value of $203 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Matrix Capital Management Company, LP
Waltham, MA |
Nov 14, 2024 Q3 2024 |
13,959,973
shares
|
$43.7 Million
2.45% of portfolio
|
Q2 2023
Added 51.74%
|
|
Eventide Asset Management, LLC
Boston, MA |
Nov 14, 2024 Q3 2024 |
8,547,896
shares
|
$26.8 Million
0.55% of portfolio
|
Q2 2024
Reduced 26.15%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,818,546
shares
|
$15.1 Million
0.0% of portfolio
|
Q2 2024
Added 3.72%
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
4,612,707
shares
|
$14.4 Million
0.0% of portfolio
|
Q3 2024
Reduced 18.43%
|
|
Decheng Capital LLC
Menlo Park, CA |
Nov 14, 2024 Q3 2024 |
3,108,095
shares
|
$9.73 Million
2.71% of portfolio
|
Q3 2024
Added 1.23%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
2,717,521
shares
|
$8.51 Million
0.0% of portfolio
|
Q3 2024
Reduced 39.65%
|
|
Decheng Capital Management Iii (Cayman), LLC
|
Nov 13, 2023 Q3 2023 |
2,099,583
shares
|
$6.57 Million
23.31% of portfolio
|
Q2 2023
Added 15.07%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
1,611,567
shares
|
$5.04 Million
0.0% of portfolio
|
Q3 2024
Reduced 17.39%
|
|
Verition Fund Management LLC
Greenwich, CT |
Nov 14, 2024 Q3 2024 |
1,504,320
shares
|
$4.71 Million
0.03% of portfolio
|
Q3 2024
Added 172.12%
|
|
Primecap Management CO
Pasadena, CA |
Nov 08, 2024 Q3 2024 |
1,498,030
shares
|
$4.69 Million
0.0% of portfolio
|
Q3 2024
Added 21.56%
|
|
Bio Impact Capital LLC
Cambridge, MA |
Nov 12, 2024 Q3 2024 |
1,465,801
shares
|
$4.59 Million
0.84% of portfolio
|
Q3 2024
Added 1.09%
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,292,100
shares
|
$4.04 Million
0.0% of portfolio
|
Q3 2024
Reduced 3.17%
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,246,613
shares
|
$3.9 Million
0.0% of portfolio
|
Q3 2024
Reduced 59.16%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
1,149,400
shares
|
$3.6 Million
0.01% of portfolio
|
Q3 2024
Added 44.23%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
1,128,577
shares
|
$3.53 Million
0.0% of portfolio
|
Q3 2024
Added 369.57%
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
1,055,282
shares
|
$3.3 Million
0.04% of portfolio
|
Q3 2024
Reduced 30.44%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
1,036,911
shares
|
$3.25 Million
0.0% of portfolio
|
Q3 2024
Added 12.23%
|
|
Opaleye Management Inc.
Boston, MA |
Nov 14, 2024 Q3 2024 |
967,000
shares
|
$3.03 Million
0.65% of portfolio
|
Q3 2024
New holding
|
|
Tybourne Capital Management (Hk) LTD
Hong Kong, K3 |
Nov 14, 2024 Q3 2024 |
961,486
shares
|
$3.01 Million
1.27% of portfolio
|
Q2 2023
Reduced 41.1%
|
|
Almitas Capital LLC
Santa Monica, CA |
Nov 14, 2024 Q3 2024 |
960,928
shares
|
$3.01 Million
1.65% of portfolio
|
Q3 2024
New holding
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
908,601
shares
|
$2.84 Million
0.01% of portfolio
|
Q3 2024
Reduced 13.66%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
886,086
shares
|
$2.77 Million
0.0% of portfolio
|
Q3 2024
Added 125.69%
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
775,536
shares
|
$2.43 Million
0.0% of portfolio
|
Q3 2024
Added 52.59%
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
634,064
shares
|
$1.98 Million
0.0% of portfolio
|
Q3 2024
Added 2.39%
|
|
Gsa Capital Partners LLP
London, X0 |
Nov 05, 2024 Q3 2024 |
608,585
shares
|
$1.9 Million
0.17% of portfolio
|
Q3 2024
Added 138.47%
|